Danish industry pleads device cause:
This article was originally published in Clinica
Executive Summary
An organogram of Denmark's new Medicines Agency makes no mention of medical devices, despite the fact that device regulation will be the responsibility of the pharmacotherapeutic secretariat. The Danish Medical Device Association (DMDA) says it hopes the importance of devices will be upgraded in the new organisation (see Clinica No 746, p 2). On May 1st, the DMDA was due to meet Ib Bo Lumholtz, who took over as director of the Medicines Agency on March 1st, to discuss the allocation of resources to the device area.